The ameliorative effects of a hypnotic bromvalerylurea in sepsis

Biochemical and Biophysical Research Communications
Satoshi KikuchiJunya Tanaka

Abstract

Sepsis is a severe pathologic event, frequently causing death in critically ill patients. However, there are no approved drugs to treat sepsis, despite clinical trials of many agents that have distinct targets. Therefore, a novel effective treatment should be developed based on the pathogenesis of sepsis. We recently observed that an old hypnotic drug, bromvalerylurea (BU) suppressed expression of many kinds of pro- and anti-inflammatory mediators in LPS- or interferon-γ activated alveolar and peritoneal macrophages (AMs and PMs). Taken the anti-inflammatory effects of BU on macrophages, we challenged it to septic rats that had been subjected to cecum-ligation and puncture (CLP). BU was subcutaneously administered to septic rats twice per day. Seven days after CLP treatment, 85% of septic rats administrated vehicle had died, whereas administration of BU reduce the rate to 50%. Septic rats showed symptoms of multi-organ failure; respiratory, circulatory and renal system failures as revealed by histopathological analyses, blood gas test and others. BU ameliorated these symptoms. BU also prevented elevated serum-IL-6 level as well as IL-6 mRNA expression in septic rats. Collectively, BU might be a novel agent to ameliorate sepsis ...Continue Reading

References

Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C J LowensteinW J Murphy
Jan 11, 1995·JAMA : the Journal of the American Medical Association·M S Rangel-FraustoR P Wenzel
Jul 1, 1996·Critical Care Medicine·R C Bone
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jan 29, 2008·Biochimica Et Biophysica Acta·Hisaaki TakahashiJunya Tanaka
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Jul 10, 2012·Nature Medicine·Sarah C P Williams
Sep 4, 2013·Critical Care : the Official Journal of the Critical Care Forum·Fernando Souza-Fonseca-GuimaraesMinou Adib-Conquy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Contributions to Nephrology
Marco FormicaMary Lou Wratten
Nihon rinsho. Japanese journal of clinical medicine
Kenji Okajima
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
M ZhouPing Wang
© 2022 Meta ULC. All rights reserved